Stock market update: Nifty Pharma index falls 2.87%
Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...
This pharma stock tanks 20 per cent even as markets trade higher - Here's why
Image Source : PIXABAY The counter opened gap down with a loss of 18.96 per cent.
Apellis Pharmaceuticals (NASDAQ:APLS investor one-year losses grow to 58% as the stock sheds US$231m this past week
Taking the occasional loss comes part and parcel with investing on the stock market. And there's no doubt that ...
devdiscourse11h
Pharma Sector Drags British Stocks as Sterling Strengthens
British stocks had a mixed finish on Friday due to a stronger sterling and losses in the pharma sector. While the FTSE 100 ...
Hosted on MSN14h
Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs
Novartis NVS and AbbVie ABBV announced small M&A deals. The FDA approved the expanded use of Pfizer’s PFE cancer drug ...
Stock market update: Nifty Pharma index falls 0.44% in an upbeat market
AM(IST)on Friday in an upbeat market. Torrent Pharmaceuticals Ltd.(up 1.67 per cent), Aurobindo Pharma Ltd.(up 1.22 per cent) ...
Novo Nordisk stock is having a rough week after that Hims & Hers Super Bowl ad
Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...
S&P 500 Gains and Losses Today: MGM Stock Surges as Macau, Digital Businesses Thrive
The S&P 500 advanced 1.0% on Thursday, Feb. 13, as an executive order deferred the possible implementation of reciprocal ...
Investopedia14d
Vertex Pharmaceuticals Stock Jumps as Non-Opioid Painkiller Gets FDA Approval
JOSEPH PREZIOSO / AFP via Getty Images Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration. The drugmaker said the twice-daily pill, Journavx ...
Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?
Teva reported fourth-quarter revenue of $4.2 billion, beating analyst estimates of $4.13 billion, according to Benzinga Pro. The company reported fourth-quarter adjusted earnings of 71 cents per share ...